That might be one of the reasons why we observed the different trends in survival curves between breast cancer and lung adenocarcinoma with wild-type TP53 and high/low BCAR1 expression, although there was no statistical significance in both cancer patients. The gene discussed is TP53; the disease is breast cancer.